Literature DB >> 25227751

Protective factors in diabetic retinopathy: focus on blood-retinal barrier.

Conghui Zhang1, Hao Wang, Jing Nie, Fang Wang.   

Abstract

The earliest and most significant change in diabetic retinopathy (DR) is blood-retinal barrier (BRB) dysfunction, followed by two main pathologies that may cause severe visual impairment: Diabetic Macular Edema (DME) and Proliferative Diabetic Retinopathy (PDR). The pathological hallmarks of BRB dysfunction include loss of tight junction integrity, VEGF- and AGE-induced damage, oxidative stress, and inflammatory changes. Recently, several BRB protective factors have been reported. Our aim is to give a review of those protective factors and discuss new potential therapeutic targets for DR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25227751

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  19 in total

1.  Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway.

Authors:  Tianyu Zhang; Hao Ouyang; Xiyu Mei; Bin Lu; Zengyang Yu; Kaixian Chen; Zhengtao Wang; Lili Ji
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

2.  Differential expression of breast cancer-resistance protein, lung resistance protein, and multidrug resistance protein 1 in retinas of streptozotocin-induced diabetic mice.

Authors:  Meng-Shuang Li; Meng Xin; Chuan-Long Guo; Gui-Ming Lin; Jun Li; Xiang-Gen Wu
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

3.  Occludin downregulation in high glucose is regulated by SSTR2 via the VEGF/NRP1/Akt signaling pathway in RF/6A cells.

Authors:  Mengling Li; Shuaiwei Wang; Songjiang Wang; Lei Zhang; Dongdong Wu; Ruisheng Yang; Ailing Ji; Yanzhang Li; Jun Wang
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

4.  Protective effects of lycium barbarum polysaccharides on blood-retinal barrier via ROCK1 pathway in diabetic rats.

Authors:  Jihong Wang; Yong Yao; Xuezheng Liu; Kelei Wang; Qianqian Zhou; Ying Tang
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

5.  An eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy.

Authors:  Fernanda Pacella; Maria Rosaria Romano; Paolo Turchetti; Giovanna Tarquini; Anna Carnovale; Antonella Mollicone; Alessandra Mastromatteo; Elena Pacella
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

6.  Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial-mesenchymal transition and endothelial injury by suppressing MAPK activation.

Authors:  Tian Liu; Jing Zhao; Chengmin Lin
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

7.  Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy.

Authors:  Finny Monickaraj; Paul McGuire; Arup Das
Journal:  FASEB J       Date:  2017-12-20       Impact factor: 5.191

8.  Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey.

Authors:  Y Lim; S Chun; J H Lee; K H Baek; W K Lee; H-W Yim; M-I Kang
Journal:  Osteoporos Int       Date:  2016-02-16       Impact factor: 4.507

9.  Antioxidant-Rich Extract from Plantaginis Semen Ameliorates Diabetic Retinal Injury in a Streptozotocin-Induced Diabetic Rat Model.

Authors:  Thing-Fong Tzeng; Wayne Young Liu; Shorong-Shii Liou; Tang-Yao Hong; I-Min Liu
Journal:  Nutrients       Date:  2016-09-18       Impact factor: 5.717

10.  TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.

Authors:  Feng Jiang; Qingzhong Chen; Liming Huang; Ying Wang; Zhuhong Zhang; Xiangda Meng; Yuanyuan Liu; Chunjie Mao; Fang Zheng; Jingkai Zhang; Hua Yan
Journal:  Int J Mol Sci       Date:  2016-04-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.